BioSpace News Archive

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, presented 96-week data from its global phase III FLAIR study of the investigational, long-acting, injectable, 2-drug regimen of ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine for the treatment of HIV.

The U.S. Food and Drug Administration today approved Ofev (nintedanib) oral capsules to treat patients with chronic fibrosing (scarring) interstitial lung diseases (ILD) with a progressive phenotype (trait). It is the first FDA-approved treatment for this group of fibrosing lung diseases that worsen over time.

A national medical society on Sunday recognized a study from the JFK Johnson Stroke-HEART™ Trials as the best research published last year in the field’s most prestigious journal.

Gilead Sciences Inc. (Nasdaq: GILD) today announced data from the BRAAVE 2020 study, a Phase 3 clinical trial evaluating the safety and efficacy of switching to Biktarvy® (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg tablets, BIC/FTC/TAF) in virologically suppressed adults living with HIV who self-identified as Black or African American.

COCRYSTAL PHARMA, INC. announced that it has entered into definitive agreements with several institutional investors for the purchase of 5,037,038 shares of its common stock at a price of $1.35 per share, for aggregate gross proceeds of approximately $6.8 million, in a registered direct offering priced at-the-market under Nasdaq rules.

Curadigm, an early-stage nanotechnology company committed to improving treatment outcomes by redefining the therapeutic balance between bioavailability, toxicity, and efficacy, announced the selection of its Nanoprimer technology by the National Cancer Institute’s (NCI) Nanotechnology Characterization Laboratory (NCL) for characterization, based on its potential to significantly impact treatments in multiple disease indications, including cancer.

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Brinda Balakrishnan , M.D., Ph.D., has been named to the San Francisco Business Times 2020 “40 Under 40" list. Now in its ninth year, the San Francisco Business Times “40 Under 40" list highlights the Bay Area’s best and brightest young business and community le

As coronavirus paralyzes the world with fear, bioscience enterprise The Gilla Company has developed and independently tested a product shown to be at least 99.9% effective in killing the deadly virus.

The Branford Group, a Global Industrial Auction Company, in conjunction with Prestige Auctions will conduct a series of 2 Online Auctions to sell the assets of formerly Micro Machine Company located at 2429 N. Burdick Street, Kalamazoo, MI & 4130 Corridor Drive, Warsaw, IN..

Altima Dental is celebrating a record-breaking year after increasing the total number of dental clinics by 60% and adding over $160 million in partnership value in 2019.